|
|
|
|
 |
|
|
 |
News |
|
|
18 08 2010
TORONTO, ONTARIO--(Marketwire - Aug. 18, 2010) - Titan Medical Inc. ("Titan" or the "Company") (TSX VENTURE:TMD) is pleased to announce its results for the three and six months ended June 30, 2010. The financial statements and Management's Discussion and Analysis for the period may be viewed on SEDAR. |
| |
|
18 08 2010
TORONTO, ONTARIO--(Marketwire - Aug. 18, 2010) - Titan Medical Inc. ("the Company") (TSX VENTURE:TMD) announces that it has granted 150,000 options to Officers, employees and consultants of the company on August 17, 2010. |
| |
|
10 08 2010
TORONTO, ONTARIO--(Marketwire - Aug. 10, 2010) - Titan Medical Inc. ("the Company") (TSX VENTURE:TMD) is pleased to announce today that it has appointed Dr. John R. Valvo, M.D., F.A.C.S., to its Medical Advisory Board. |
| |
|
27 07 2010
TORONTO, ONTARIO--(Marketwire - July 27, 2010) - Titan Medical Inc. ("the Company") (TSX VENTURE:TMD) is pleased to announce the signing of a non-binding memorandum of understanding (MOU) with Rochester General Hospital. |
| |
|
26 07 2010
TORONTO, ONTARIO--(Marketwire - July 26, 2010) - Titan Medical Inc. ("the Company") (TSX VENTURE:TMD) announces that it has granted 76,000 options to two directors and 100,000 options to three scientific advisors to the company on July 15, 2010. |
| |
|
05 07 2010
TORONTO, ONTARIO--(Marketwire - July 5, 2010) - Titan Medical Inc. (TSX VENTURE:TMD) announced today that it has filed an amended and restated preliminary short form base shelf prospectus with the securities regulatory authorities in each of the provinces of British Columbia, Alberta and Ontario. |
| |
|
04 06 2010
TORONTO, ONTARIO--(Marketwire - June 4, 2010) - Titan Medical Inc. ("the Company") (TSX VENTURE:TMD) announces that it has granted 600,000 options to a senior officer of the company on June 4, 2010. Each option entitles its holder to purchase one common share of Titan at a price of $0.30 for a period of five years from the date of grant. The options vest, as to 150,000 options, every six months from the date of grant. All shares issuable upon exercise of the options shall be subject to resale restrictions, under the policies of the TSX Venture Exchange, for a period of 4 months from the date of grant. |
| |
|
02 06 2010
TORONTO, ONTARIO--(Marketwire - June 2, 2010) - Titan Medical Inc. ("the Company") (TSX VENTURE:TMD) is pleased to announce the appointment of Mr. Joseph Talarico as the Senior Vice President, Business Development, a newly created position, for the Company. Mr. Talarico has been involved in the surgical medical device industry for over seven years, most notably with Intuitive Surgical, Inc. for five years. |
| |
|
19 05 2010
TORONTO, ONTARIO--(Marketwire - May 19, 2010) - Titan Medical Inc. ("Titan" or the "Company") (TSX VENTURE:TMD) is pleased to announce its results for the three months ended March 31, 2010. The financial statements and Management's Discussion and Analysis for the period may be viewed on SEDAR. |
| |
|
19 04 2010
TORONTO, ONTARIO--(Marketwire - April 19, 2010) - Titan Medical Inc. ("the Company") (TSX VENTURE:TMD) is pleased to announce that it has selected KUKA Robotics Corporation, a world leading supplier of industrial robots, to supply its Lightweight Robot (LWR) to be integrated with Amadeus, a next generation robotic surgical system currently under development by the Company. |
| |
|
|
|
